Hormonal factors of virus-associated cancer of the cervix uteri

Objective: to study the urinary levels of estrogen metabolites as a diagnostic criterion in patients with cancer of the cervix uteri (CCU) associated with human papillomavirus (HPV) infection to provide a rationale for the use of pathogenetic therapy in the combination treatment of CCU.
Subjects and methods. The study enrolled 26 patients with Stages I-IV CCU who were treated at the Department of Gynecology, Tomsk Research Institute of Oncology. The patients’ mean age was 45.6±1.3 years (range 24 to 72 years), the patients of reproductive age ac- counted for 50%. Tumor was staged in accordance with the FIGO classification. Genotyping was carried out on 12 oncotropic types, by estimating the viral load by polymerase chain reaction. Urinary estrogen metabolite levels were measured in all patients.
Results. In the female patients, the urinary level of the metabolite 2-OHE1 responsible for normal cell growth was 8.95±2.9 ng/mg, which was significantly below the values in healthy women (19.7±1.2 ng/mg). The level of the metabolite 16

1. GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide. IARC CancerBaseN5,verson2.0. IARCPress.2004.

2. Коломиец, Л.А.,ЧуруксаеваО.Н.,Уразова Л.Н. и др. Вакцинация против ВПЧ - первичная профилактика рака шейки матки.Томск,2008. 79с.

3. GLOBOCAN database. – http://www-dep.iarc.fr/ last access 25.01.2007.

4. Козаченко В. П. Вакцинопрофилактика рака шейки матки. Вместе против рака 2008;(3):23-5.

5. ACS annual statistics: American Cancer Society – Cancer Statistics. http://www.Cancer.Org/docroot/STT/STT_0.Asp.

6. Коломиец Л.А., Уразова Л.Н. Генитальная папилломавирусная инфекция и рак шейки матки. Томск: Изд-во НТЛ, 2002. 100 с.

7. Вергейчик Г.И. Роль генотипа вируса папилломы человека в развитии эпителиальных дисплазий и преинвазивного рака шейки матки у женщин в Республике Беларусь. Акуш и гинекол 2008;(2):44-6.

8. Сухих Г. Т., Аполихина И. А., Лопатина Т. В. и др. Диагностика, профилактика и лечение папилломавирусной инфекции гениталий у женщин: учебное пособие. М., 2010. 47 с.

9. Munos N. Human papillomavirus and cancer: theepidemiologicalevidence.JClinVirol 2000;19:1-5.

10. Walboomers J. M., Jacobs M.V., Manos M.M.etal.Humanpapillomavirusisanecessary cause of invasive cervical cancer wordwide. J Pathol 1999;189:12-9.

11. Clifford G.M., Smith J.S., Plummer M. et al. Human papillomavirus types in invasive cervical cancer wordwide: A meta-analysis. Br J Cancer 2003; 88:66-73.

12. Del Mistro A., Frayle Salamanca H., Trevisan R. et al. Human papillomavirus typing in invasive cervical cancer in Italy. Infect Agent Cancer 2006;1:9.

13. Gargiulo F., De Francesco M.A., Schreiber C. et al. Prevalence and distribution of single and multiple HPV infections in cytologically abnormal cervical samples from Italian women. Virus res 2007;125:176-82.

14. Ricciardi A., Largeron N., Rossi P.G. et al. Incidence of invasive cervical cancer and direct costs associated with its management in Italy. Tumori 2009;95(2):146-52.

15. Киселев В. И. Вирусы папилломы человека в развитии рака шейки матки. М.: Изд-во Димитрейд График Групп, 2004.184 с.

16. Ашрафян Л.А.,Киселев В.И. Опухоли репродуктивных органов (этиология и патогенез). М.: Изд-во Димитрейд График Групп,2008.216с.

17. Ваганова И. Г. Апоптоз и пролиферация эпителиоцитов эктоцервикса у больных папилломавирусным и хламидийным цервицитом. Вопр онкол 2004; 46(5):578-82.

18. Koskela P., Anttila T., Bjorge T. et al. Chlamydia trachomatis infection as a risk factor for invasive cervical cancer. Int J Cancer 2000;85:35-9.

19. Backe J., Roos T., Mulfinger L., Martius J. Arch Gynecol Obstet 1997; 259:69-77.

20. Chang D. Y., Chen R. J., Lee S.C., Huang S. C. Prevalence of single and multiple infection with human papillomaviruses in various grades of cervical neoplasia. J Med Microbiol 1997; 46 (1): 54–60.

21. Ашрафян Л.А., Киселев В.И., Муйжнек Е.Л. Патогенетическая профилактика рака репродуктивных органов. М.: Изд-во Дими- трейд График Групп, 2009. 176 с.